USF Health neuroscientist Cesario Borlongan, PhD, was selected to deliver the Donald D. Matson Lecture at the 84th Annual Scientific Meeting of the American Association of Neurological Surgeons (AANS).
Dr. Borlongan, a world leader in stem cell therapy for stroke, spoke May 2 on the topic “Stem Cell Therapy for Pediatric Disorders” at the AANS meeting in Chicago. The lecture he gave is named in honor of Dr. Donald Darrow Matson, a pioneer of pediatric neurosurgery who made seminal contributions to the field.
Cesario Borlongan, PhD
Dr. Borlongan is a professor of neurosurgery and director of the Center of Excellence for Aging and Brain Repair at the USF Health Morsani College of Medicine. His translational bench to clinic research has led to five FDA-approved clinical trials of cell transplantation, including the world’s first cell therapy in stroke patients. He served as a National Institutes of Health staff fellow for five years, and joined the academe in 2002.
Author of more than 310 peer-reviewed publications, lead editor of two books and editor of many scientific journals, including Stem Cells, Stroke, JCBFM, PLoS One and Brain Research, he is also a regular study section member of NIH, Veterans Affairs, the Department of Defense, and the American Heart Association, and chairs the State of Maryland Stem Cell Research Funds.
He is an American Association for the Advancement of Science (AAAS) Fellow and serves as president of the American Society for Neural Therapy and Repair and the International Placenta Stem Cell Society.